Return To Results
An efficacy and safety study of investigational drug (XP13512) compared with a concurrent placebo control in subjects with neuropathic pain associated with post-herpetic neuralgia (PHN)
- Study Location
- Rehabilitation Institute of Chicago
- IRB Protocol Number
- STU00003138
- Investigator(s)
- R. Norman Harden MD
- Study Objective
This study is being done because researchers want to find out if a study drug (XP13512) is safe and whether it can help people with pain associated with post-herpetic neuralgia (PHN) by improving their physical and emotional well-being.
- Compensation
- Provided
- Who Can Participate
Individuals with chronic pain as a result of post-herpetic neuralgia
Provided (You will get up to $942.80 if you finish the entire study. If you do not finish the entire study, you will get $43.70 for each study visit completed, plus additional stipends of $126.35 at certain visits.)
- Enrollment
- Active Research Studies Currently Recruiting
- How To Participate
- Center for Pain Studies 312-238-5654 centerforpainstudies@ric.org